Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CNB Financial Pref | CCNEP | Nov 15, 2024 | 25.17 | -0.51 |
CNFinance ADR | CNF | Nov 15, 2024 | 1.06 | -2.75 |
CNH Industrial N.V. | CNH | Nov 15, 2024 | 10.90 | +2.25 |
CNO Financial Group | CNO | Nov 15, 2024 | 38.95 | -0.26 |
CNS Pharmaceuticals | CNSP | Nov 15, 2024 | 0.11 | -11.61 |
CNX Resources | CNX | Nov 15, 2024 | 38.19 | -0.65 |
Co-Diagnostics | CODX | Nov 15, 2024 | 1.06 | -3.64 |
Coastal Financial | CCB | Nov 15, 2024 | 73.32 | +0.03 |
Coca-Cola | KO | Nov 15, 2024 | 61.74 | -1.30 |
Coca-Cola Consolidated | COKE | Nov 15, 2024 | 1 210.70 | -0.37 |
Coca-Cola Europacific Partners | CCEP | Nov 15, 2024 | 75.76 | -3.82 |
Coca-Cola FEMSA ADR | KOF | Nov 15, 2024 | 77.56 | +0.17 |
Cocrystal Pharma | COCP | Nov 15, 2024 | 2.15 | -2.27 |
Coda Octopus | CODA | Nov 15, 2024 | 8.74 | +0.81 |
Codere Online Luxembourg | CDRO | Nov 15, 2024 | 7.90 | -1.99 |
Codexis | CDXS | Nov 15, 2024 | 3.88 | +3.74 |
Coeptis Therapeutics | COEP | Nov 15, 2024 | 0.20 | -3.16 |
Coeur Mining | CDE | Nov 15, 2024 | 6.14 | -1.44 |
Coffee Holding Company | JVA | Nov 15, 2024 | 3.23 | +5.21 |
Cogent Biosciences | COGT | Nov 15, 2024 | 8.90 | -7.77 |
Cogent Communications | CCOI | Nov 15, 2024 | 79.40 | +2.04 |
Cognex | CGNX | Nov 15, 2024 | 39.61 | -2.27 |
Cognition Therapeutics | CGTX | Nov 15, 2024 | 0.46 | -9.85 |
Cognizant Technology Solutions A | CTSH | Nov 15, 2024 | 77.11 | -4.53 |
Cognyte Software | CGNT | Nov 15, 2024 | 6.92 | -2.12 |
Cohen & Company | COHN | Nov 15, 2024 | 9.70 | -1.92 |
Cohen & Steers | CNS | Nov 15, 2024 | 100.47 | -0.25 |
Cohen & Steers Closedend Opportunity Fund | FOF | Nov 15, 2024 | 12.74 | -0.86 |
Cohen & Steers Duration Pref and Income Fund | LDP | Nov 15, 2024 | 20.88 | -0.71 |
Cohen & Steers Infrastructure Fund | UTF | Nov 15, 2024 | 24.90 | +0.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.